
|Videos|July 17, 2014
<em>ESR1</em> Mutations in Primary Breast Cancer
Author(s)Suzanne A. W. Fuqua, PhD
Suzanne A. W. Fuqua, PhD, professor of medicine at Baylor College of Medicine, discusses ESR1 mutations in primary breast cancer.
Advertisement
Clinical Pearls
Suzanne A. W. Fuqua, PhD, professor of medicine at Baylor College of Medicine, discussesESR1mutations in primary breast cancer.
- There is some controversy surrounding whether or notESR1mutations are associated with primary breast cancer.
- It has been reported that the K303R mutation was present in premalignant breast cancer as well as in primary breast tumors.
- Further research is needed to validate the presence and frequency of the K303R mutation in primary breast cancer.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts NDA for Daraxonrasib in Metastatic Pancreatic Cancer
2
Advanced Renal Cell Carcinoma: Tailoring Second-Line Therapy After Prior Immunotherapy
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Teclistamab/Talquetamab Reduces Risk of Progression by 89% in R/R Multiple Myeloma
5































